Nakamura, Nobuhiko http://orcid.org/0000-0003-1682-7777
Kasahara, Senji
Kitagawa, Junichi
Nakamura, Hiroshi
Sawada, Michio
Fukuno, Kenji
Shibata, Yuhei
Kaneda, Yuto
Hara, Takeshi
Kanemura, Nobuhiro
Tsurumi, Hisashi
Shimizu, Masahito
Clinical trials referenced in this document:
Documents that mention this clinical trial
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
https://doi.org/10.1186/s40164-022-00264-3
Article History
Received: 26 October 2021
Accepted: 16 February 2022
First Online: 25 February 2022
Declarations
:
: Ethics approval was granted by the institutional review board at each participating institution. All patients provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.